RECRUITING

Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.

Official Title

Mechanisms and Utility of Multisensory Body- Representation in SCI and SCI-Related Neuropathic Pain

Quick Facts

Study Start:2023-10-17

Study Completion:2026-10-20

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06010251

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Men or women 2. fluent in English 3. 18-70 years of age who have: (3a) Complete and incomplete SCI, level of injury (above L1); (3b) Persistent neuropathic pain started after the injury for a minimum of three months prior to entering the study that is at least moderate in severity, defined as ≥ 4 on a Numeric Rating Scale (NRS) ranging 0 to 10.	1. Major psychiatric disease/disorder (self-reported); 2. a significant neurological trauma (self-reported) other than SCI; 3. a recent (one-year) history of alcohol or drug abuse assessed by the Drug Abuse Screening Test (DAST-10) 4. history of visual and hearing loss not corrected 5. history of epilepsy or seizures 6. any metal implants in the head, or implanted devices such as cochlea implants or cardiac pacemakers.

Inclusion Criteria

Exclusion Criteria

1. Men or women
2. fluent in English
3. 18-70 years of age who have: (3a) Complete and incomplete SCI, level of injury (above L1); (3b) Persistent neuropathic pain started after the injury for a minimum of three months prior to entering the study that is at least moderate in severity, defined as ≥ 4 on a Numeric Rating Scale (NRS) ranging 0 to 10.

1. Major psychiatric disease/disorder (self-reported);
2. a significant neurological trauma (self-reported) other than SCI;
3. a recent (one-year) history of alcohol or drug abuse assessed by the Drug Abuse Screening Test (DAST-10)
4. history of visual and hearing loss not corrected
5. history of epilepsy or seizures
6. any metal implants in the head, or implanted devices such as cochlea implants or cardiac pacemakers.

Contacts and Locations

Study Contact

Eva Widerstrom-Noga, PhD

CONTACT

(305)243-7125

ewiderstrom-noga@med.miami.edu

Roberta Vastano, PhD

CONTACT

754 207 3627

rxv331@miami.edu

Principal Investigator

Eva Widerstrom-Noga, PhD

PRINCIPAL_INVESTIGATOR

University of Miami

Study Locations (Sites)

University of Miami

Miami, Florida, 33136

United States

Collaborators and Investigators

Sponsor: University of Miami

Eva Widerstrom-Noga, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-17

Study Completion Date2026-10-20

Study Record Updates

Study Start Date2023-10-17

Study Completion Date2026-10-20

Terms related to this study

Additional Relevant MeSH Terms

Spinal Cord Injuries
Neuropathic Pain